<ul>&#13;<br>&#9;<li>Wells Fargo cut the price target for <strong> Marathon Oil Corporation </strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRO#NYSE">MRO</a>) from $40 to $38. Wells Fargo analyst Roger Read maintained an Overweight rating. Marathon Oil shares fell 0.3% to $24.72 in pre-market trading.</li>&#13;<br>&#9;<li>JP Morgan increased the price target for <strong> CenterPoint Energy, Inc. </strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>) from $32 to $34. JP Morgan analyst Jeremy Tonet maintained an Overweight rating. CenterPoint Energy shares rose 0.8% to close at $30.64 on Monday.</li>&#13;<br>&#9;<li>Goldman Sachs slashed the price target for <strong> Twist Bioscience Corporation </strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) from $43 to $20. Goldman Sachs analyst Matthew Sykes maintained a Neutral rating. Twist Bioscience shares fell 1.8% to $14.43 in pre-market trading.</li>&#13;<br>&#9;<li>Rosenblatt cut <strong> Viavi Solutions Inc. </strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) price target from $16 to $13. Rosenblatt analyst Mike Genovese maintained a Buy rating. Viavi Solutions shares rose 0.7% to $9.38 in pre-market trading.</li>&#13;<br>&#9;<li>Jefferies increased <strong> Okta, Inc. </strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) price target from $100 to $105. Jefferies analyst Joseph Gallo maintained a Buy rating. Okta shares rose 1.1% to $78.62 in pre-market trading.</li>&#13;<br>&#9;<li>Wells Fargo cut the price target for <strong> M&amp;T Bank Corporation </strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) from $155 to $145. Wells Fargo analyst Christopher Spahr maintained an Equal-Weight rating. M&amp;T Bank shares fell 0.1% to $125.50 in pre-market trading.</li>&#13;<br>&#9;<li>Jefferies boosted <strong> Microsoft Corporation </strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) price target from $310 to $325. Jefferies analyst Brent Thill maintained a Buy rating. Microsoft shares rose 0.9% to close at $288.80 on Monday.</li>&#13;<br>&#9;<li>Citigroup cut <strong> Baidu, Inc. </strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) price target from $191 to $186. Citigroup analyst Alicia Yap maintained a Buy rating. Baidu shares rose 2.2% to close at $131.54 on Monday.</li>&#13;<br>&#9;<li>HSBC boosted <strong> NVIDIA Corporation </strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) price target from $175 to $355. HSBC analyst Frank Lee upgraded the stock from Reduce to Buy. NVIDIA shares gained 0.9% to close at $270.02 on Monday.</li>&#13;<br>&#9;<li>Morgan Stanley cut <strong> Helmerich &amp; Payne, Inc. </strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) price target from $60 to $45. Morgan Stanley analyst Daniel Kutz downgraded the stock from Equal-Weight to Underweight. Helmerich &amp; Payne shares fell 1.3% to $36.39 in pre-market trading.</li>&#13;<br>&#9;<li>Atlantic Equities boosted <strong> Comcast Corporation </strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) price target from $36 to $44. Atlantic Equities analyst Hamilton Faber upgraded the stock from Neutral to Overweight. Comcast shares rose 1% to $38.45 in pre-market trading.</li>&#13;<br></ul>&#13;<br>&#13;<br><p>Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/04/31852478/nn-and-2-other-stocks-under-2-insiders-are-aggressively-buying"><em> NN And 2 Other Stocks Under $2 Insiders Are Aggressively Buying </em></a></p>&#13;<br> <p>Copyright &#169; Benzinga. All rights reserved. Write to editorial@benzinga.com with any questions about this content. Benzinga does not provide investment advice.</p>